StockVS

Churchill Capital Corp X (CCCX) Aktienanalyse

Finanzdienstleistungen

Churchill Capital Corp X

$13.66

+$0.45 (+3.37%)

Zuletzt aktualisiert: 13. Februar 2026

Kursverlauf

Analyse

Unternehmensübersicht

Churchill Capital Corp X operates as a special purpose acquisition company, also known as a shell company, whose primary focus is effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more target entities. The company functions within the Financial Services sector, specifically under the industry classification of Shell Companies, a designation that signifies its role as a publicly traded entity waiting for a strategic business combination rather than a traditional operating business with established products or services. As of the latest available data, the enterprise holds a market capitalization of $711.00M, yet its annual revenue is reported as N/A, and the number of employees is listed as N/A. These valuation figures indicate that the company's market value is derived primarily from its potential for future business combinations and the expectations of the market regarding such deals, rather than from historical revenue generation or a large existing workforce, which is typical for entities in the shell company stage prior to a definitive merger.

Finanzielle Gesundheit

The company reports a net income of $-31,429,724 over the trailing twelve-month period, while both revenue and EBITDA figures are recorded as N/A. The substantial negative net income in the absence of reported revenue suggests a cost structure heavily weighted toward acquisition-related expenses, transaction costs, and potentially interest on outstanding obligations rather than operating expenses tied to product sales or service delivery. Free cash flow is not available in the financial records, which limits the assessment of the company's immediate financial flexibility to generate capital for operations or further acquisitions without external financing. All three margin metrics—gross margin, operating margin, and profit margin—are stated at 0.0%, indicating that the company has not yet generated positive gross profit or operating income relative to its sales, or that no sales data exists to calculate these ratios. In terms of liquidity and leverage, the company holds $1.14M in cash against N/A in reported debt, resulting in a debt-to-equity ratio that is not applicable due to missing equity data, while the current ratio stands at 0.04. This current ratio of 0.04 reveals a significant liquidity constraint, indicating that current assets are less than one-quarter of current liabilities, which poses a risk to short-term solvency if immediate obligations arise. Return on Equity and Return on Assets are both listed as N/A, reflecting the fact that traditional return metrics are difficult to evaluate for a shell company with minimal or negative earnings and no substantial asset base prior to a merger.

Bewertungsanalyse

The trailing twelve-month P/E ratio and forward P/E ratio are both listed as N/A, which implies that traditional earnings-based valuation methods cannot be applied to determine expected earnings trajectories given the lack of positive net income. The price-to-book ratio is recorded at -18.71, a negative figure that indicates the market price is significantly below the book value of equity, a condition often seen in SPACs with substantial deferred underwriting fees or accumulated losses that reduce tangible book value. Price-to-sales and EV/EBITDA ratios are unavailable, suggesting that alternative valuation metrics relying on sales or operating cash flow are not applicable due to the lack of reported revenue or EBITDA data. Regarding trading range, the stock has a 52-week high of $27.50 and a 52-week low of $10.03, meaning the current market price sits somewhere within this band, reflecting the volatility inherent in the shell company sector. The beta value is not available, which prevents a quantitative assessment of the stock's price volatility relative to the broader market, though the wide spread between the high and low suggests significant price fluctuation over the past year.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both recorded as N/A, precluding any analysis of whether earnings are growing faster or slower than revenue due to the absence of historical revenue data. The company does not pay a dividend, as the dividend yield and payout ratio are both listed as N/A and 0.0% respectively, indicating that the company does not distribute cash to shareholders but instead retains its limited cash reserves of $1.14M. Since the company is not a dividend payer, it effectively reinvests its earnings—or rather, its lack thereof—into the pursuit of business combinations rather than providing income returns to investors. Consequently, the overall growth and income profile of Churchill Capital Corp X is characterized by a complete lack of historical growth metrics and dividend income, relying entirely on the successful execution of a future merger to create value for shareholders.

Vergleich mit Mitbewerbern

Churchill Capital Corp X (CCCX) ist in der Mantelgesellschaften-Branche tätig. So schneidet das Unternehmen im Vergleich zu seinen nächsten Mitbewerbern nach Marktkapitalisierung ab:

Unternehmen Ticker Marktkapitalisierung KGV
Churchill Capital Corp X CCCX $711.00M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5
Bain Capital GSS Investment Corp. BCSS $595.68M N/A

Das durchschnittliche KGV der Mantelgesellschaften-Branche beträgt 82.8x. Churchill Capital Corp X wird mit einem KGV von N/A gehandelt.

Diese Analyse wurde von KI erstellt und dient nur zu Informationszwecken. Sie stellt keine Finanzberatung dar. Daten können verzögert oder ungenau sein. Führen Sie immer Ihre eigene Recherche durch und konsultieren Sie einen qualifizierten Finanzberater, bevor Sie Anlageentscheidungen treffen.

Über Churchill Capital Corp X

As of February 13, 2026, Churchill Capital Corp X was acquired by ColdQuanta, Inc., in a reverse merger transaction. Churchill Capital Corp X focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2024 and is based in New York, New York.

Die Unternehmensbeschreibung wird auf Englisch angezeigt.

Wichtige Kennzahlen

Marktkapitalisierung
$711.00M
KGV
N/A
52-Wochen-Hoch
$27.50
52-Wochen-Tief
$10.03
Durchschn. Volumen
2.12M

Daten bereitgestellt von Yahoo Finance über yfinance. Täglich aktualisiert.

Unternehmensinfo

Börse
NASDAQ
Land
United States